Graphene Shows Potential as Novel Anti-Cancer Therapeutic Strategy
Researchers have shown that graphene oxide, a modified form of graphene, acts as an anti-cancer agent that selectively targets cancer stem cells. In combination with existing treatments, this could eventually lead to tumor shrinkage as well as preventing the spread of cancer and its recurrence after treatment. [Press release from the University of Manchester discussing online publication in Oncotarget] Press Release|Full Article
Natural Grape Extracts Regulate Colon Cancer Cells Malignancy
Liofenol™ induced an important morphology change in HCT116 cells, migration inhibition, undifferentiated stem/stem-like cells markers downregulation, and E-cadherin downregulation, interested in epithelia to mesenchymal malignant transition. [Nutr Cancer] Abstract
Prognostic Significance of CD44v6, CD133, CD166, and ALDH1 Expression in Small Intestinal Adenocarcinoma
CD44v6, CD133, CD166, and ALDH1 have been proposed to be putative cancer stem cell markers in gastrointestinal malignancies. Researchers investigated the expressions of CD44v6, CD133, CD166, and ALDH1 and evaluated their relationships with clinicopathologic parameters including the survival data in small intestinal adenocarcinoma. [Appl Immunohistochem Mol Morphol] Abstract
Visit our reviews page to see a complete list of reviews in the cancer stem cell research field.
INDUSTRY NEWS
CPRIT Awards 58 Research Grants to Advance the Fight Against Cancer
The Cancer Prevention and Research Institute of Texas (CPRIT) awarded four grants through its product development research program and 54 grants through its academic research program. With a total requested amount of $48.5 million, these grants will fund projects focused on taking promising cancer treatments and therapies from the laboratory into clinical practice. [CPRIT] Press Release
MD Anderson Joins CATCH® Global Foundation to Boost Child Health, Prevent Cancer in Later Years
The University of Texas System Board of Regents approved the agreement that makes MD Anderson a founding partner in the foundation. Coordinated Approach to Child Health (CATCH®) is a program developed and disseminated by The University of Texas Health Science Center at Houston School of Public Health. [The University of Texas MD Anderson Cancer Center] Press Release
Recruit Top Talent: Reach more than 60,000 potential candidates by posting
your organization’s career opportunities on the Connexon Creative Job Board at no cost.
Have we missed an important article or publication in Cancer Stem Cell News? Click here to submit!